Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and radiological correlates of apathy in multiple sclerosis.
Tazza F, Schiavi S, Leveraro E, Cellerino M, Boffa G, Ballerini S, Dighero M, Uccelli A, Sbragia E, Aluan K, Inglese M, Lapucci C. Tazza F, et al. Mult Scler. 2024 Feb;30(2):247-256. doi: 10.1177/13524585231217918. Epub 2023 Dec 14. Mult Scler. 2024. PMID: 38095151
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis.
Cellerino M, Schiavi S, Lapucci C, Sbragia E, Boffa G, Rolla-Bigliani C, Tonelli S, Boccia D, Bruschi N, Tazza F, Franciotta D, Inglese M. Cellerino M, et al. Among authors: tazza f. Front Neurosci. 2023 Apr 11;17:1112199. doi: 10.3389/fnins.2023.1112199. eCollection 2023. Front Neurosci. 2023. PMID: 37113155 Free PMC article.
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities.
Lapucci C, Tazza F, Rebella S, Boffa G, Sbragia E, Bruschi N, Mancuso E, Mavilio N, Signori A, Roccatagliata L, Cellerino M, Schiavi S, Inglese M. Lapucci C, et al. Among authors: tazza f. Front Neurol. 2023 Mar 8;14:1084661. doi: 10.3389/fneur.2023.1084661. eCollection 2023. Front Neurol. 2023. PMID: 36970546 Free PMC article.
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.
Schiavetti I, Barcellini L, Lapucci C, Tazza F, Cellerino M, Capello E, Franciotta D, Inglese M, Sormani MP, Uccelli A, Laroni A. Schiavetti I, et al. Among authors: tazza f. Mult Scler Relat Disord. 2023 Feb;70:104494. doi: 10.1016/j.msard.2022.104494. Epub 2022 Dec 30. Mult Scler Relat Disord. 2023. PMID: 36603292 Free PMC article.
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M, Germano F, Grisanti S, Castellano C, Tazza F, Mobilia EM, Visigalli D, Novi G, Massa F, Rossi S, Durando P, Cabona C, Schenone A, Franciotta D, Benedetti L. Bellucci M, et al. Among authors: tazza f. Front Immunol. 2022 Jul 18;13:894872. doi: 10.3389/fimmu.2022.894872. eCollection 2022. Front Immunol. 2022. PMID: 35924236 Free PMC article.
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Among authors: tazza f. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
13 results